Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
What Does Index Level Tell Us summarizes the core takeaways from index readings, offering a straightforward lens to interpret trends and potential moves.
19,344 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A Tuesday surge in Uber stock sparked curiosity among investors. This article dives into the catalysts, profitability...
A Bitcoin Policy Institute study reveals that AI systems weigh Bitcoin more heavily than traditional currencies and s...
As major retailers push Beyond Meat into the frozen aisle, investors debate the stock's trajectory. This guide breaks...
A new stake lift from Bright Valley Capital highlights a high-stakes bet on Vipshop’s rebound. We break down what it ...
When regulators and exchanges join forces to reverse a settlement, it signals a new chapter in crypto enforcement. Th...
Insider moves often spark questions when a stock rallies. This article examines Nayax's CMO sale during a solid run, ...
When a company’s chairman unloads a sizable stake, investors naturally want to know why. This article breaks down a r...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
A Supreme Court ruling nullifies broad tariffs, but a mid-sized U.S. coffee roaster warns refunds are unlikely and co...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...